Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

3 passages

referencesuptodate· REFERENCES· item f38_11_39096

REFERENCES American Academy of Pediatrics/American Heart Association Clarification of Statement on Cardiovascular Evaluation and Monitoring of Children and Adolescents With Heart Disease Receiving Medications for ADHD; available at: file://americanheart.mediaroon.com/index.php?s=43&item=422. Barrickman LL, Petty PJ, Allen AJ, et al, “Bupropion Versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder,” J Am Acad Child Adolesc Psychiatry , 1995, 34(5):649-57. [PubMed 7775360 ] Conners CK, Casat CD, Gualtieri CT, et al, “Bupropion Hydrochloride in Attention Deficit Disorder With Hyperactivity,” J Am Acad Child Adolesc Psychiatry , 1996, 35(10):1314-21. [PubMed 8885585 ] Davidson J, “Seizures and Bupropion: A Review,” J Clin Psychiatry , 1989, 50(7):256-61. [PubMed 2500425 ] Daviss WB, Perel JM, Birmaher B, et al, "Steady-State Clinical Pharmacokinetics of Bupropion Extended-Release in Youths," J Am Acad Child Adolesc Psychiatry , 2006, 45(12):1503-9. [PubMed 17135996 ] Dopheide JA, "Recognizing and Treating Depression in Children and Adolescents," Am J Health Syst Pharm , 2006, 63(3):233-43. [PubMed 16434782 ] Hack S, "Pediatric Bupropion-Induced Serum Sickness Like Reaction," J Child Adolesc Psychopharmacol , 2004, 14(3):478-80. [PubMed 15650506 ] Jennison TA, Brown P, Crossett J, et al, “A High-Performance Liquid Chromatographic Method for Quantitating Bupropion in Human Plasma or Serum,” J Anal Toxicol , 1995, 19(2):69-72. [PubMed 7769789 ] Kavoussi RJ, Segraves RT, Hughes AR, et al, “Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients,” J Clin Psychiatry , 1997, 58(12):532-7. [PubMed 9448656 ] Leverich GS, Altshuler LL, Frye MA, et al, “Risk of Switch in Mood Polarity to Hypomania or Mania in Patients with Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers,” Am J Psychiatry , 2006, 163(2):232-9. [PubMed 16449476 ] McIntyre RS, Mancini DA, McCann S, et al, “Topiramate Versus Bupropion SR When Added to Mood Stabilizer Therapy for the Depressive Phase of Bipolar Disorder: A Preliminary Single-Blind Study,” Bipolar Disord , 2002, 4(3):207-13. [PubMed 12180276 ]

referencesuptodate· REFERENCES· item f38_11_39096

Leverich GS, Altshuler LL, Frye MA, et al, “Risk of Switch in Mood Polarity to Hypomania or Mania in Patients with Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers,” Am J Psychiatry , 2006, 163(2):232-9. [PubMed 16449476 ] McIntyre RS, Mancini DA, McCann S, et al, “Topiramate Versus Bupropion SR When Added to Mood Stabilizer Therapy for the Depressive Phase of Bipolar Disorder: A Preliminary Single-Blind Study,” Bipolar Disord , 2002, 4(3):207-13. [PubMed 12180276 ] Muramoto ML, Leischow SJ, Sherrill D, et al, "Randomized, Double-Blind, Placebo-Controlled Ttrial of 2 Dosages of Sustained-Release Bupropion for Adolescent Smoking Cessation," Arch Pediatr Adolesc Med , 2007, 161(11):1068-74. [PubMed 17984409 ] Pass SE and Simpson RW, “Discontinuation and Reinstitution of Medications During the Perioperative Period,” Am J Health Syst Pharm , 2004, 61(9):899-912. [PubMed 15156966 ] Pliszka SR, Crismon ML, Hughes CW, et al, "The Texas Children’s Medication Algorithm Project: Revision of the Algorithm for Pharmacotherapy of ADHD," J Am Acad Child Adolesc Psychiatry , 2006, 45(6):642-57. [PubMed 16721314 ] Riggs PD, Leon SL, Mikulich SK, et al, “An Open Trial of Bupropion for ADHD in Adolescents With Substance Use Disorders and Conduct Disorder,” J Am Acad Child Adolesc Psychiatry , 1998, 37(12):1271-8. [PubMed 9847499 ] Spencer T, Biederman J, Kerman K, et al, “Desipramine Treatment of Children With Attention-Deficit Hyperactivity Disorder and Tic Disorder or Tourette's Syndrome,” J Am Acad Child Adolesc Psychiatry , 1993, 32(2):354-60. [PubMed 8444765 ] Turpeinen M, Koivuviita N, Tolonen A, et al, "Effect of Renal Impairment on the Pharmacokinetics of Bupropion and Its Metabolites," Br J Clin Pharmacol , 2007, 64(2):165-73. [PubMed 17335546 ] Van Wyck FJ, Manberg PJ, Miller LL, et al, “Overview of Clinically Significant Adverse Reactions to Bupropion,” J Clin Psychiatry , 1983, 44(5 Pt 2):191-6. [PubMed 6406456 ] Vetter VL, Elia J, Erickson C, et al, "Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing," Circulation , 2008, 117(18):2407-23. [PubMed 18427125 ]

referencesuptodate· REFERENCES· item f38_11_39096

Vetter VL, Elia J, Erickson C, et al, "Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing," Circulation , 2008, 117(18):2407-23. [PubMed 18427125 ] Wagner KD, "Pharmacotherapy for Major Depression in Children and Adolescents," Prog Neuropsychopharmacol Biol Psychiatry , 2005, 29(5):819-26. [PubMed 15908090 ] Wilens TE, Prince JB, Spencer T, et al, “An Open Trial of Bupropion for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder,” Biol Psychiatry , 2003, 54(1):9-16. [PubMed 12842303 ] Topic 12719 Version 46.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0505-91.202.164.29-7B7E1375F2-S244013.14]